Original Contributions |
From the Vascular Biology Unit (H.D.W., P.J.P., Y.D., A.J.C., P.B., R.A.C.), Robert Dawson Evans Department of Clinical Research, Department of Medicine, Boston University School of Medicine, Boston, Mass, and the Department of Veterinary Molecular Biology (M.T.Q.), Montana State University, Bozeman.
Correspondence to Dr Richard A. Cohen, MD, Vascular Biology Unit, R408, Boston University School of Medicine, 80 E Concord St, Boston, MA 02118. E-mail racohen{at}med-med1.bu.edu
| Abstract |
|---|
|
|
|---|
Key Words: NADPH oxidase nitro blue tetrazolium lucigenin diphenylene iodonium
| Introduction |
|---|
|
|
|---|
We found that in the aorta of normal rabbits, the greatest amount of superoxide anion is produced in the adventitia by an NADPH oxidase that is localized to the plasma membrane fraction.17 In the normal rabbit aorta, the superoxide anion activity is nearly completely scavenged by endogenous SOD activity, being easily measured only after SOD activity is inhibited by diethyldithiocarbamate.2 When SOD activity is inhibited, the levels of superoxide anion rise to levels sufficient to inhibit nitric oxideinduced relaxation1 and to induce alterations in gene expression.9
Steinhorn et al18 showed that delivery of nitric oxide to either the intimal or adventitial surfaces of rabbit pulmonary artery produced markedly different responses. There was a reduced vasodilatory response when nitric oxide was added to the adventitial compared with the intimal surface. Although the mechanism for this difference in vasodilator response was not explained, these authors observed that the route of administration did not lead to differences in relaxation to carbon monoxide or sodium nitroprusside.
The purpose of the present study was to determine whether superoxide anion is produced endogenously in the rat aortic adventitia and whether sufficient superoxide anion is produced to interfere with the response of the rat aorta to nitric oxide. To quantify the low levels of superoxide anion produced by the aorta, we used NBT, which becomes gradually reduced by superoxide anion during incubation, accumulating the product, blue formazan. This allows not only for quantification of superoxide anion production but also for histological localization of the site of production. We also confirmed that superoxide anion was being produced primarily by the adventitia by measuring lucigenin chemiluminescence and by showing that NADPH oxidase protein subunits were localized almost exclusively in the adventitia. The data presented here indicate that the primary site of superoxide anion production in the normal rat aorta is the adventitia, which constitutes a significant barrier to exogenous nitric oxide reaching the smooth muscle.
| Materials and Methods |
|---|
|
|
|---|
The endothelium was removed by inserting a polyethylene tube (PE-50) into the lumen of the aorta and rolling the vessel on moistened gauze. After cutting a segment from the aorta, the aorta was inverted by tying the vessel onto one end of the tubing and then pulling the aorta over the tubing. After another segment was cut off, the aorta was reinverted by pulling it back over the tubing. Rings 5 mm long were cut from the segments and mounted on triangular stirrups for isometric tension recording in organ chambers containing 25 mL of buffer. This resulted in three groups of rings. One group of rings was oriented with the adventitia facing outward. The second group was oriented with the intimal surface facing outward. The third group of rings, which had been inverted twice, was oriented with the adventitia facing outward and served as a control for potential cellular injury caused by stretching the smooth muscle during the inverting procedure. The rings were then mounted on the triangular stirrups and suspended in organ baths. Rings were maintained at 37°C and pH 7.4 by gassing with 95% O2/5% CO2. After equilibration for 60 minutes at the optimal resting tension (5 g), the aortic smooth muscle was contracted with phenylephrine hydrochloride. After achieving a stable contraction, cumulative concentrations of nitric oxide (10-10 to 10-6 mol/L) or sodium nitroprusside (10-10 to 10-5 mol/L) were added in the presence or absence of SOD (150 U/mL). Experiments with sodium nitroprusside were routinely performed in the dark. At the end of the experiment, acetylcholine (10-7 to 10-6 mol/L) was added to assess the functional integrity of the endothelium. Rings that did not respond to acetylcholine were considered effectively denuded of endothelium. This procedure provided a method for the delivery of drugs preferentially to the intimal and adventitial aspects of the aorta. When suspended under the optimal resting tension, the ring is stretched between the two stirrups approximating the opposing sides of the ring, which limits diffusion of nitric oxide to the apposing faces. This procedure was found to be more feasible for demonstrating the functional role of the adventitia than were attempts to strip the adventitia from the media, which caused more damage and total loss of the ability of the smooth muscle to contract.
Detection of Superoxide Anion by NBT Reduction
Aortic rings were incubated with NBT in order to allow
superoxide anion generated by the tissue to reduce the NBT to blue
formazan.19 The site of superoxide anion could be
visualized in the intact ring, and the amount of the superoxide anion
generated by the vessel could be quantified by measuring the absorbance
of blue formazan extracted from the tissue. Furthermore, the enzymatic
source of superoxide anion in the vessels was determined
pharmacologically by using different antagonists. Aortic
rings were cut into transverse rings 6 mm in length. The rings
were then transferred into test tubes containing 5 mL of buffer and
maintained at 37°C and gassed with 95% O2/5%
CO2 for 30 minutes in the presence or the absence
of Euk-8 (100 µmol/L, a synthetic SOD
mimic20 21 ), SOD (150 U/mL), DPI (100
µmol/L, an NADPH oxidase inhibitor), oxypurinol (300
µmol/L, a xanthine oxidase inhibitor), rotenone (50
µmol/L, a mitochondrial oxidase inhibitor), or L-NAME
(300 µmol/L, a nitric oxide synthase inhibitor). The
concentration of Euk-8 that was used has an approximate SOD activity of
100 U/mL, an activity comparable to that of the authentic SOD used.
Rings were then placed in 5 mL buffer composed of (mmol/L) NaCl 119,
HEPES 20, KCl 4.6, MgSO4 1.0,
Na2HPO4 0.15,
KH2PO4 0.4,
NaHCO3 5, CaCl2 1.2, and
glucose 5.5 (pH 7.4) and containing NBT (100 µmol/L) in the
presence or absence of the scavengers or the enzyme
inhibitors for 1 to 1.5 hours. Five milliliters of 0.5N HCl
was added to stop the reaction. In each case in which an
inhibitor was used, a simultaneous control ring
was used for comparison.
Some rings were then fixed in 4% formalin and embedded in paraffin. The surface of the paraffin block was cut with a microtome, and the block was placed on a microscope stage and photographed directly with epi-illumination and transillumination. Efforts to cut and prepare histological sections resulted in significant solubilization and leaching of blue formazan from the tissue.
As described by Pourcyrous et al,19 NBT reduction
was quantified in some rings treated with SOD or Euk-8 after they were
minced and homogenized in a mixture of 0.1N NaOH and 0.1%
SDS in water containing 40 mg/L of diethylenetriaminepentaacetic acid.
The mixture was centrifuged at 20 000g for 20
minutes. The resultant pellet was resuspended in 1.5 mL of pyridine
during heating at 80°C for 1 to 1.5 hours to extract formazan. The
mixtures were subjected to a second centrifugation at
10 000g for 10 minutes as previously
described.19 The absorbance of formazan was
determined spectrophotometrically at 540 nm. The extinction coefficient
of blue formazan is 0.72 L ·
mmol-1 · mm-1.
The quantity of formazan was calculated as follows: NBT
reduction=AxV/(TxWtx
xl), where A is the absorbance of blue
formazan at 540 nm, V is the volume of the solution, T is the time
period during which rings were incubated with NBT, Wt is the blotted
wet weight of the artery ring,
is the extinction coefficient, and l
is the length of the light path. Results are reported as picomoles per
minute per milligram wet weight of artery. Extraction efficiency was
nearly 100%, as estimated from extracting homogenates of
normal aortic rings, which were mixed with known quantities of blue
formazan.
To determine the amount of NBT that was nonenzymatically
reduced,22 we incubated a ring of boiled aorta
with NBT under conditions similar to the above; this value is reported
in the results but is not subtracted from the reported values for
intact rings. The SDS and NaOH in the extraction media appeared to
reduce NBT to blue formazan during the extraction only in rings treated
with DPI. Therefore, extractions of rings from experiments with all the
enzyme inhibitors (Figure 6
) were performed without SDS and
NaOH. Omitting SDS and NaOH did not significantly affect the recovery
of the blue color from the aortic pellet from the rings. When extracted
with SDS and NaOH, the NBT reduction for a control rat aortic ring was
27±7 pmol · min-1 · mg
tissue-1 (n=11), and the value for rings
extracted without SDS and NaOH was 23±7 pmol ·
min-1 · mg
tissue-1 (n=11). This indicates that the
recovery of blue formazan was not significantly different for the two
extraction methods used.
|
Tests of the specificity of this assay showed that NBT reduction is >600-fold less sensitive to H2O2 than to superoxide anion. Optical density at 550 nm 15 seconds after adding 1 and 100 mmol/L H2O2 was 0.001 and 0.030, respectively, whereas that for 1 mmol/L potassium superoxide was 0.620. The small reduction of NBT by 100 mmol/L H2O2 was unaffected by catalase, whereas that caused by potassium superoxide was reduced by SOD (150 U/mL) to 0.024. This substantiates that the NBT assay is specific for superoxide anion rather than H2O2.
Detection of Superoxide Anion by Lucigenin
Chemiluminescence
The details of this assay have been published
previously.17 Briefly, aortic rings were cut into
transverse rings 7 mm in length. The rings were cut
longitudinally, flattened, and tied with 3-0 silk suture to a small
black plastic plate either with adventitial or intimal surfaces facing
outward. The rings were then transferred into test tubes containing 5
mL of buffer, maintained at 37°C, and gassed with 95%
O2/5% CO2 for 45 minutes.
Rings were then placed in 1 mL of HEPES buffer containing lucigenin
(250 µmol/L) and maintained at 37°C. The luminometer was set
to report arbitrary units of light emitted and integrated over a
30-second interval; repeated measurements were made over 5 minutes and
averaged. Tiron (10 mmol/L), a nonenzymatic scavenger of
superoxide anion, was then added to quench the chemiluminescence;
readings from the last 90 seconds of an additional 5-minute period were
averaged.
Immunohistochemistry
To identify the source of superoxide production in the
adventitia, we analyzed frozen sections of rat aorta using
immunohistochemistry with monoclonal antibodies recognizing four NADPH
oxidase proteins known to be essential for NADPH oxidase activity in
leukocytes.23 Thoracic aorta was removed
sterilely from male Wistar rats, embedded in OCT, and snap-frozen on
dry ice. Immunohistochemistry was performed using previously
characterized monoclonal antibodies specifically recognizing
gp91phox,24
p22phox,24
p47phox,25 and
p67phox.25 Frozen aortas
were cryosectioned at 5 µm. The sections were air-dried for 1
hour, fixed in cold acetone for 10 minutes, air-dried again for 1 hour,
washed with blotto (5% skim milk+0.1% Tween 20 in Dulbecco's PBS, pH
7.6), and blocked with 10% goat serum in blotto for 30 minutes. The
sections were then incubated overnight with control nonimmune mouse
serum or monoclonal antibodies (all at
20 µg/mL) in Dulbecco's
PBS containing 1% bovine serum albumin, 0.1% Tween 20, 0.1%
NaN3, and 1% goat serum. After washing five
times for 5 minutes with blotto, the sections were incubated for 60
minutes at 25°C with 5-nm gold-conjugated goat anti-mouse antibody
(Goldmark Biologicals) diluted 1:50 in the same buffer as used for the
primary antibodies.26 The sections were rinsed
with H2O, developed using silver acetate
enhancement in the dark,26 and counterstained
using Nuclear Fast Red (Vector Laboratories).
Drugs
Acetylcholine chloride, lucigenin, phenylephrine
hydrochloride, L-NAME, NBT, oxypurinol, rotenone, sodium nitroprusside,
and Tiron were purchased from Sigma Chemical Co. SOD was purchased from
Fluka. DPI was purchased from Biomol. Euk-8 was generously supplied by
Eukarion Inc. All drugs were made fresh just before each experiment.
Drugs were added to the incubation solution in aliquots of <1% of the
solution volume. DPI and rotenone were prepared in pure dimethyl
sulfoxide. Oxypurinol was solubilized in 0.5N NaOH and diluted to a
stock concentration in distilled water. All other drugs were prepared
as stock solutions in distilled water.
Data Analysis
ANOVA for repeated measures was applied to the data for all the
concentration-response curves by using the SAS software package.
Simultaneous multiple comparisons were based on post hoc
comparison procedures using a Student-Newman-Keuls test. A paired
t test was applied to the data for the NBT reduction and
lucigenin chemiluminescence.
| Results |
|---|
|
|
|---|
|
Figure 1
shows examples of recorded
changes in tension (1) in rings that were mounted with the adventitia
facing outward (adventitia out), (2) in rings that were mounted with
the adventitia positioned inside after inverting the ring (lumen out,
inverted), or (3) in rings that were inverted twice to control for the
inverting procedure (adventitia out, reinverted). Nitric oxide
(10-8 mol/L) caused a small relaxation in rings
in which the luminal surface was oriented outward but not in the rings
whose adventitial surfaces were exposed. Nitric oxide
(10-7 mol/L) still induced a larger relaxation
in the inverted rings compared with the rings whose adventitia was
oriented outward (inverted twice or not inverted). In the presence of
SOD (150 U/mL), the nitric oxideinduced relaxation was improved more
in the rings whose adventitial surfaces were oriented outward than in
the inverted rings.
|
The relaxations to nitric oxide expressed as a percentage of the
contractions induced by phenylephrine are shown in Figure 2
. Nitric oxide
(10-10 to 10-8
mol/L)induced relaxations were significantly shifted to the right in
the rings whose adventitial side was oriented outward (either before or
after inverting twice) compared with relaxations in the rings whose
luminal surface was directed outward (n=6 for adventitia-out rings, n=6
for lumen-out rings, and n=7 for adventitia-out reinverted rings;
P<.01). At nitric oxide concentrations of
10-9, 10-8, or
10-7 mol/L, respective relaxation values were
(on average) 15%, 32%, and 43% lower in the rings whose adventitial
surface was oriented outward compared with the rings whose luminal
surface was outward (P<.01). At the higher concentration of
nitric oxide (10-6 mol/L), there were no
significant differences observed among the groups. The relaxation to
nitric oxide of the rings whose adventitial surface was exposed before,
or after inverting twice, were not significantly different.
|
In the presence of SOD (150 U/mL), the responses to nitric oxide were similar among the groups regardless of whether the adventitial or luminal surface was oriented outward (n=6 for rings with adventitia out, n=5 for inverted rings, and n=5 for reinverted rings; P>.05).
In contrast to the results obtained with nitric oxide, sodium
nitroprusside caused similar relaxations in rings whether the
adventitial surface (before or after inverting twice) or luminal
surface (inverted once) was oriented outward (Figure 3
) (n=5 for rings with adventitia out and
n=6 for rings with lumen out, P>.05). In rings with the
adventitia oriented outward, SOD (150 U/mL) had no significant effects
on relaxation caused by sodium nitroprusside (n=8) or papaverine (n=8),
a nitric oxideindependent vasodilator (Figure 3
).
|
Tissue Site and Quantification of Superoxide Anion
Production by NBT Reduction
Incubation of rings with NBT resulted in blue staining of the
adventitia (Figure 4
). In rings that were
inverted, the adventitia was also stained blue, despite its being
oriented inward, indicating that superoxide anion was generated mainly
in the adventitia regardless of its physical orientation. The
superoxide scavengers, SOD and Euk-8, visibly decreased the intensity
of the blue staining (not shown). The effect of Euk-8 was greater than
the effect of SOD.
|
The NBT reduction quantified in aortic rings is shown in Figure 5
. In control aortic rings, the NBT
reduction was 31±2 pmol · min-1 · mg
wet wt-1. SOD and Euk-8 significantly decreased
the NBT reduction to 19±2 and 11±2 pmol ·
min-1 · mg wet
wt-1, respectively (n=7, P<.01
compared with control). NBT reduction was inhibited more by Euk-8 than
by SOD (P<.05). Nonenzymatic NBT reduction determined in a
boiled ring (10 pmol · min-1 · mg
wet wt-1) was similar to that obtained in rings
treated with Euk-8, suggesting that NBT reduction persisting in the
presence of Euk-8 was nonenzymatic.
|
The effects of inhibitors of different enzymatic sources of
superoxide anion are shown in Figure 6
.
DPI (100 µmol/L), an NADPH oxidase inhibitor,
significantly reduced NBT reduction from 27±2 to 9±1 pmol ·
min-1 · mg wet
wt-1, a value similar to that obtained with
boiled tissue. In contrast, neither the NADH dehydrogenase
inhibitor, rotenone (50 µmol/L), nor the xanthine
oxidase inhibitor, oxypurinol (300 µmol/L),
significantly decreased NBT reduction. L-NAME (300 µmol/L), a
nitric oxide synthase inhibitor, also did not significantly
affect NBT reduction (P>.05).
Detection of Superoxide Anion Production by Lucigenin
Chemiluminescence
Lucigenin chemiluminescence was significantly higher in aortic
rings in which the adventitia was facing outward than in aortic rings
in which the intimal surface was facing outward (13±1.7 versus
7.6±0.6 mU/mg wet wt, respectively; P<.05).
Chemiluminescence after adding Tiron was reduced and similar in aortic
rings with the adventitia or intima facing outward (6±0.6 versus
6.4±0.7 mU/mg wet wt, respectively). After subtracting lucigenin
chemiluminescence in the presence of Tiron from that obtained in its
absence, the Tiron-quenchable chemiluminescence was significantly
higher with the adventitia facing outward (7.3±1.8 versus 1.1±0.3
mU/mg wet wt, respectively; P<.05).
Immunohistochemical Detection of NADPH Oxidase Proteins in Rat
Aortic Adventitia
As shown in Figure 7
, immunohistochemistry of sections of rat aorta revealed specific
labeling of the adventitia with monoclonal antibodies against human
phagocyte p22phox and
gp91phox and recombinant
p47phox and p67phox,
whereas no substantial staining was observed in other areas of the
aorta.
|
| Discussion |
|---|
|
|
|---|
It might be argued that the influence of orientation on the response to nitric oxide of aortic rings might be related to the reduced contractile response to phenylephrine that occurred as a result of inverting the arterial rings. However, the responses to nitric oxide in the rings that were inverted twice and in which contractile force was reduced to a similar extent were also shifted to the right compared with the responses of the rings whose luminal surfaces were exposed. This indicates that it is the orientation rather than the altered smooth muscle contraction that results in the difference in response to nitric oxide.
Because it is difficult not to damage the endothelium when inverting the aorta, the present experiments were carried out in endothelium-denuded rings. The relaxation to nitric oxide of rings with an intact endothelium and the adventitia oriented outward was similar to that of rings without endothelium (data not shown), indicating that removal of the endothelium was not responsible for the reduced sensitivity to nitric oxide of rings oriented with the lumen oriented inward.
Unlike authentic nitric oxide, sodium nitroprusside induced similar relaxations when administered to rings regardless of the orientation of the adventitial or luminal surface. Steinhorn et al18 also found that the adventitia of the rabbit pulmonary artery interfered with relaxation caused by nitric oxide but not sodium nitroprusside. This difference may be due to the fact that if care is taken to perform experiments in the dark, sodium nitroprusside primarily releases nitric oxide intracellularly in smooth muscle cells,28 where it would be inaccessible to extracellular superoxide anion. The similar relaxation to sodium nitroprusside administered to either aspect of the vascular wall, as well as the lack of an effect of SOD on the relaxation, therefore supports the suggestion that it is extracellular superoxide anion in the adventitia that acts as a barrier to exogenous authentic nitric oxide. The equal relaxations to sodium nitroprusside also exclude a nonspecific difference arising as a result of the differences in orientation or differences in contraction of the inverted rings. Finally, the lack of effect of SOD on sodium nitroprusside or papaverine-induced relaxations indicates that SOD lacks nonspecific effects, which might have otherwise accounted for its effect on nitric oxideinduced relaxation.
The adventitial source of superoxide anion was demonstrated by blue formazan staining of rings incubated with NBT. The blue staining of the adventitia was decreased by SOD, consistent with the localization of extracellular superoxide anion as the functional barrier to nitric oxide administered to the adventitial aspect of the blood vessel. The staining of the adventitia was not related to better NBT penetration of the adventitia oriented outwardly, as demonstrated by similar staining of the adventitia in inverted rings. Incubation of the rabbit thoracic aorta with NBT also resulted in blue formazan staining mainly in the adventitia, but in that blood vessel, the staining occurred only after endogenous SOD was inhibited with diethyldithiocarbamate.29 In the rat, sufficient superoxide anion was generated in the aortic adventitia to be detected under normal conditions. This could be due to increased production or decreased scavenging of the free radical.
The production of superoxide anion in the adventitia could be quantified by measuring the amount of NBT reduction. We used this indicator in the present study because NBT reduction is very sensitive to low levels of superoxide anion as a result of the accumulation of blue formazan in the tissue over time. It is therefore an integrative measurement of the very low production of superoxide anion produced under basal conditions. The specificity of the NBT assay was further indicated by showing that the superoxide anion scavengers, SOD and Euk-8, decreased the reduction of NBT and that H2O2 did not significantly reduce NBT by comparison. SOD decreased NBT reduction to a lesser extent than did Euk-8. This may be due to the indication that Euk-8 is a cell-permeant superoxide scavenger20 and that it may gain access to superoxide anion produced intracellularly. In contrast, at least in the short term, exogenous SOD only has access to superoxide anion generated extracellularly, since it is repelled from cells because of its negative charge.27 The difference in the effects of SOD and Euk-8 may suggest that approximately half of the measurable superoxide anion is extracellular. The amount of NBT reduction in Euk-8treated tissue was similar to that in boiled tissue, suggesting that this residual was nonenzymatic, possibly resulting from reduction of NBT by thiols or other tissue chemical constituents.22
DPI decreased NBT reduction to the same levels as found after Euk-8 treatment or boiling, suggesting that the majority of NBT reduction is accounted for by superoxide anion production by an NADPH oxidase in rat aortic adventitia. This finding is consistent with previous results in rabbit thoracic aorta.17 That rotenone had no significant effect indicates that the major source of superoxide anion is not mitochondrial NADH dehydrogenase. We can also exclude xanthine oxidase as a significant source of superoxide anion in the aorta, because oxypurinol did not decrease NBT reduction. We confirmed this pharmacological and biochemical evidence by showing the presence of neutrophil-like NADPH oxidase subunit proteins localized almost exclusively in the adventitia. This further establishes the adventitia as being a site of superoxide anion production.
It is possible that the inducible form of nitric oxide synthase is
expressed in the adventitia of rat aorta by
endotoxin,30 to which the blood vessel is exposed
after removal from the rat. Because nitric oxide synthases, like other
NADPH-dependent cytochrome P450 reductases, can
reduce NBT,31 32 it is possible that this enzyme
could account for the NBT staining observed.33
This possibility is, however, unlikely to explain our findings, because
neither L-NAME nor
N
-nitro-L-arginine (data not
shown) had a significant effect on NBT reduction in the adventitia. In
addition, treatment of the rat aorta with cycloheximide (20
µmol/L) throughout the course of experiments similar to those
reported here failed to affect the development of NBT staining (not
shown). Because this protein synthesis inhibitor blocks the
expression of inducible nitric oxide synthase,34
this, or other inducible proteins, cannot explain the superoxide
production by the adventitial cells observed in the present
study.
The greater adventitial production of superoxide anion observed in the present study was confirmed by lucigenin chemiluminescence, which was shown to be detectable predominantly from the adventitial aspect. Lucigenin is a more specific but, as a consequence of the fact that it reflects steady-state levels, a less sensitive indicator than NBT of low levels of superoxide anion produced under basal conditions. It should be pointed out that previously published results using lucigenin chemiluminescence in intact vascular rings have commonly detected light emission from the adventitial aspect of the blood vessel; therefore, our results suggest that the values reported may be weighted toward reporting adventitial production of the free radical.
We previously found that the normal rabbit aortic endothelium does not produce a sufficient concentration of nitric oxide or that it is not localized sufficiently close to the adventitia to reduce the levels of superoxide anion produced there.2 It would also appear unlikely that superoxide anion produced in the adventitia decreases the biological activity of nitric oxide produced by endothelial cells in normal arteries. This is suggested by the fact that scavenging of superoxide anion with SOD does not affect endothelium-dependent relaxations in normal arteries, including the rat aorta.35 36 37 38
It is quite possible that in disease states, such as hypertension,5 diabetes mellitus,35 or atherosclerosis,6 39 during which increased superoxide anion levels inhibit endothelium-dependent relaxation, increased adventitia-derived superoxide anion may play a role. In angiotensin IIinduced hypertension, for instance, it has been reported that superoxide anion production is increased and that this impairs acetylcholine-induced endothelium-dependent relaxation.5 In our own recent studies of this hypertensive model, which have confirmed the elevation in superoxide anion levels, the production of the free radical and the expression of NADPH oxidase proteins remain primarily localized in the adventitia.40
When superoxide anion reacts with nitric oxide, it produces the less potent vasodilators, peroxynitrite, nitrite, and nitrate.29 Thus, oxidative degradation likely explains the reduced relaxation to exogenously added nitric oxide when administered to the adventitial side of the rat aorta. In other studies (not shown), we have attempted to detect peroxynitrite both with immunohistochemical techniques directed toward nitrotyrosine41 and with luminol chemiluminescence, which can detect peroxynitrite.42 Neither technique detected peroxynitrite formed after exposing the normal rat aorta to nitric oxide, probably because peroxynitrite would be expected to be very short-lived and because nitrotyrosine was not formed in sufficient amounts. It is possible that increased levels of superoxide anion in disease states could react with nitric oxide to form significant amounts of peroxynitrite.43 This might be expected in particular if the expression of nitric oxide synthase also increased in the adventitia as part of the disease process, as it does after exposure to endotoxin.30
In addition to its role in inhibiting the activity of nitric oxide, it is possible that superoxide anion is involved in regulating growth or inflammation in the adventitia. Several recent studies have shown that the adventitia is the site of cellular proliferation after intimal injury and that adventitial fibroblasts migrate and participate in the formation of the neointima.44 45 46 In addition, the synthesis and action of growth factors may be regulated by superoxide anion. For instance, the secretion of insulin-like growth factor-1 is increased by superoxide anion.47 As demonstrated by in situ hybridization, the production of this growth factor is localized in the adventitia of the normal rat aorta,48 where its production could be under the influence of the superoxide anion shown in the present study to be produced there.
In conclusion, these data support the hypothesis that an NADPH oxidase produces superoxide anion in the vascular adventitia. The local production of superoxide anion explains the observation that the adventitia is a functional barrier to nitric oxide18 and suggests that adventitial production of superoxide anion may contribute to the regulation of vascular function.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received July 18, 1997; accepted January 28, 1998.
| References |
|---|
|
|
|---|
2.
Pagano PJ, Tornheim K, Cohen RA. Superoxide anion
production by the rabbit thoracic aorta: effect of
endothelium-derived nitric oxide. Am J
Physiol. 1993;265:H707H712.
3.
Omar HA, Cherry PD, Mortelliti MP, Burke-Wolin T,
Wolin MS. Inhibition of coronary artery superoxide dismutase
attenuates endothelium-dependent and -independent
nitrovasodilator relaxation. Circ Res. 1991;69:601608.
4. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial SO production. J Clin Invest. 1993;91:25462551.
5. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. J Clin Invest. 1996;97:19161923.[Medline] [Order article via Infotrieve]
6.
White CR, Darley-Usmar V, Berrington WR, McAdams M,
Gore JZ, Thompson JA, Parks DA, Tarpey MM, Freeman BA. Circulating
plasma xanthine oxidase contributes to vascular dysfunction in
hypercholesterolemic rabbits. Proc Natl Acad Sci
U S A.. 1996;93:87458749.
7. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;320:454456.[Medline] [Order article via Infotrieve]
8.
Grover AK, Samson SE. Effect of superoxide radical on
Ca2+ pumps of coronary artery.
Am J Physiol. 1988;255:C297C303.
9.
Ito Y, Pagano PJ, Tornheim K, Brecher P, Cohen RA.
Oxidative stress increases glyceraldehyde-3-phosphate
dehydrogenase mRNA levels in isolated rabbit aorta. Am J
Physiol. 1996;270:H81H87.
10. Murrell GA, Francis MJ, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J. 1990;265:659665.[Medline] [Order article via Infotrieve]
11. Terada LS, Willingham IR, Rosandich ME, Leff JA, Kindt GW, Repine JE. Generation of superoxide anion by brain endothelial cell xanthine oxidase. J Cell Physiol. 1991;148:191196.[Medline] [Order article via Infotrieve]
12.
Mohazzab-H KM, Kaminski PM, Wolin MS. NADH
oxidoreductase is a major source of superoxide anion in bovine
coronary artery endothelium. Am J
Physiol. 1994;266:H2568H2572.
13.
Meier B, Radeke HH, Selle S, Younes M, Sies H, Resch K,
Habermehl GG. Human fibroblasts release reactive oxygen species in
response to interleukin-1 or tumour necrosis factor-
.
Biochem J. 1989;263:539545.[Medline]
[Order article via Infotrieve]
14. Hancock JT, Jones OTG. The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages. Biochem J. 1987;242:103107.[Medline] [Order article via Infotrieve]
15.
Mohazzab-H KM, Wolin MS. Properties of a superoxide
anion-generating microsomal NADH oxidoreductase, a potential
pulmonary artery pO2 sensor.
Am J Physiol. 1994;267:L823L831.
16.
Griendling KK, Minieri CA, Ollerenshaw JD, Alexander
RW. Angiotensin II stimulates NADH and NADPH oxidase
activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:11411148.
17.
Pagano PJ, Ito Y, Tornheim K, Gallop P, Cohen RA. An
NADPH oxidase superoxide generating system in the rabbit aorta.
Am J Physiol. 1995;268:H2274H2280.
18. Steinhorn RH, Morin FC, Russell JA. The adventitia may be a barrier specific to nitric oxide in rabbit pulmonary artery. J Clin Invest. 1994;94:18831888.
19. Pourcyrous M, Leffler CW, Bada HS, Korones SB, Busija DW. Brain superoxide anion generation in asphyxiated piglets and the effect of indomethacin at therapeutic dose. Pediatr Res. 1993;34:366369.[Medline] [Order article via Infotrieve]
20. Musleh W, Bruce A, Malfroy B, Baudry M. Effects of EUK-8, a synthetic catalytic superoxide scavenger, on hypoxia- and acidosis-induced damage in hippocampal slices. Neuropharmacology. 1994;33:929934.[Medline] [Order article via Infotrieve]
21. Doctrow SR, Huffman K, Marcus CB, Musleh W, Bruce A, Baudry M, Malfroy B. Salen-manganese complexes: combined superoxide dismutase/catalase mimics with broad pharmacological efficacy. Adv Pharmacol. 1997;38:247268.
22. Auclair C, Torres M, Hakim J. Superoxide anion involvement in NBT reduction catalyzed by NADPH-cytochrome P-450 reductase: a pitfall. FEBS Lett. 1978;89:2628.[Medline] [Order article via Infotrieve]
23. DeLeo FR, Quinn MT. Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins. J Leukoc Biol. 1996;60:677691.[Abstract]
24.
Burritt JB, Quinn MT, Jutila MA, Bond CW, Jesaitis AJ.
Topological mapping of neutrophil cytochrome b epitopes with
phage-display libraries. J Biol Chem. 1995;270:1697416980.
25.
DeLeo FR, Ulman KV, Davis AR, Jutila KL, Quinn MT.
Assembly of the human neutrophil NADPH oxidase involves binding of
p67phox and flavocytochrome b to a common
functional domain in p47phox. J Biol
Chem. 1996;271:1701317020.
26. Hacker GW, Zehbe I, Muss WH, Hauser-Kronberger C, Graf A-H, Dietze O. Immunogold-silver staining detection in situ molecular biological reaction sites. Cell Vision. 1995;2:247253.
27.
White CR, Brock TA, Chang LY, Crapo J, Briscoe P,
Ku D, Bradley WA, Gianturco SH, Gore J, Freeman BA, Tarpey MM.
Superoxide and peroxynitrite in atherosclerosis.
Proc Natl Acad Sci U S A.. 1994;91:10441048.
28.
Kowaluk EA, Seth P, Fung HL. Metabolic
activation of sodium nitroprusside to nitric oxide in vascular smooth
muscle. J Pharmacol Exp Ther. 1992;262:916922.
29. Beckman JS, Chen J, Ischiropoulos H, Crow JP. Oxidative chemistry of peroxynitrite. Methods Enzymol. 1994;233:229240.[Medline] [Order article via Infotrieve]
30. Zhang H, Chobanian AV, Brecher P. Aortic adventitia is a source of nitric oxide: a possible paracrine role [abstract]. Hypertension. 1995;26:569.
31. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 1990;347:768770.[Medline] [Order article via Infotrieve]
32.
Klatt P, Schmidt K, Uray G, Mayer B. Multiple catalytic
functions of brain nitric oxide synthase. J Biol Chem. 1993;268:1478114787.
33. Bourreau JP, Kitchener P, Kwan CY, Daniel EE. Nonendothelial aortic source of nitric oxide in Wistar-Kyoto normotensive and spontaneous hypertensive rats. Biol Signals. 1992;1:322330.[Medline] [Order article via Infotrieve]
34.
Beasley D, Eldridge M. Interleukin-1ß and tumor
necrosis factor-
synergistically induce NO synthase in rat vascular
smooth muscle cells. Am J Physiol. 1994;266:R1197R1203.
35.
Tesfamariam B, Cohen RA. Free radicals mediate
endothelial cell dysfunction caused by elevated
glucose. Am J Physiol. 1992;263:H321H326.
36. Tesfamariam B. Selective impairment of endothelium-dependent relaxations by prostaglandin endoperoxide. J Hypertens. 1994;12:4147.[Medline] [Order article via Infotrieve]
37.
Pieper GM, Mei DA, Langenstroer P, O'Rourke ST.
Bioassay of endothelium-derived relaxing factor in
diabetic rat aorta. Am J Physiol. 1992;263:H676H680.
38. Taylor PD, Poston L. The effect of hyperglycaemia on isolated rat mesenteric resistance artery function. Br J Pharmacol. 1994;113:801808.[Medline] [Order article via Infotrieve]
39. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 1993;91:25462551.
40. Wang HD, Hope SK, Cohen RA. Paracrine role of adventitial superoxide anion in mediating myogenic tone in angiotensin II-induced hypertension [abstract]. Circulation. 1997;96(suppl I):I-287.
41. Beckman JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem. 1994;375:8188.
42. Kooy NW, Royall JA. Agonist-induced peroxynitrite production from endothelial cells. Arch Biochem Biophys. 1994;310:352359.[Medline] [Order article via Infotrieve]
43. Crow JP, Beckman JS. The importance of superoxide in nitric oxide-dependent toxicity: evidence for peroxynitrite-mediated injury. Adv Exp Med Biol. 1996;387:147161.[Medline] [Order article via Infotrieve]
44.
Geary RL, Williams J, K., Golden D, Brown DG, Benjamin
ME, Adams MR. Time course of cellular proliferation, intimal
hyperplasia, and remodeling following angioplasty in monkeys with
established atherosclerosis. Arterioscler Thromb
Vasc Biol. 1996;16:3443.
45.
Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH,
Simonet L, Wilcox JN. Identification of a potential role for the
adventitia in vascular lesion formation after balloon overstretch
injury of porcine coronary arteries. Circulation. 1996;93:21782187.
46.
Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D,
Zalewski A. Adventitial myofibroblasts contribute to
neointimal formation in injured porcine coronary
arteries. Circulation. 1996;94:16551664.
47.
Delafontaine P, Ku L. Reactive oxygen species stimulate
insulin-like growth factor I synthesis in vascular smooth muscle cells.
Cardiovasc Res. 1997;33:216222.
48.
Fath KA, Alexander RW, Delafontaine P. Abdominal
coarctation increases insulin-like growth factor I mRNA levels in rat
aorta. Circ Res. 1993;72:271277.
This article has been cited by other articles:
![]() |
H. Zhang, J. Zhang, Z. Ungvari, and C. Zhang Resveratrol Improves Endothelial Function: Role of TNF{alpha} and Vascular Oxidative Stress Arterioscler Thromb Vasc Biol, August 1, 2009; 29(8): 1164 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Payne, H. G. Bohlen, U. D. Dincer, L. Borbouse, and J. D. Tune Periadventitial adipose tissue impairs coronary endothelial function via PKC-{beta}-dependent phosphorylation of nitric oxide synthase Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H460 - H465. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Chang, R. G. Bonillas, S. El-ftesi, E. I. Chang, D. J. Ceradini, I. N. Vial, D. A. Chan, J. Michaels V, and G. C. Gurtner Tissue engineering using autologous microcirculatory beds as vascularized bioscaffolds FASEB J, March 1, 2009; 23(3): 906 - 915. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Wadsworth Oxidative stress and the endothelium Exp Physiol, January 1, 2008; 93(1): 155 - 157. [Full Text] [PDF] |
||||
![]() |
K. Maiellaro and W. R. Taylor The role of the adventitia in vascular inflammation Cardiovasc Res, September 1, 2007; 75(4): 640 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Auger, P. D'Orleans-Juste, and L. Germain Adventitia contribution to vascular contraction: Hints provided by tissue-engineered substitutes Cardiovasc Res, September 1, 2007; 75(4): 669 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Haurani and P. J. Pagano Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: Bellwether for vascular disease? Cardiovasc Res, September 1, 2007; 75(4): 679 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Thalmann and C. A. Meier Local adipose tissue depots as cardiovascular risk factors Cardiovasc Res, September 1, 2007; 75(4): 690 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. An, R. Boyd, M. Zhu, A. Chapman, D. R. Pimentel, and H. D. Wang NADPH oxidase mediates angiotensin II-induced endothelin-1 expression in vascular adventitial fibroblasts Cardiovasc Res, September 1, 2007; 75(4): 702 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ding, A. Chapman, R. Boyd, and H. D. Wang ERK activation contributes to regulation of spontaneous contractile tone via superoxide anion in isolated rat aorta of angiotensin II-induced hypertension Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2997 - H3005. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Zemse, R. H. P. Hilgers, and R. C. Webb Interleukin-10 counteracts impaired endothelium-dependent relaxation induced by ANG II in murine aortic rings Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3103 - H3108. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Szasz, K. Thakali, G. D. Fink, and S. W. Watts A Comparison of Arteries and Veins in Oxidative Stress: Producers, Destroyers, Function, and Disease Experimental Biology and Medicine, January 1, 2007; 232(1): 27 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhang, F. Zhang, R. Muh, F. Yi, K. Chalupsky, H. Cai, and P.-L. Li Autocrine/paracrine pattern of superoxide production through NAD(P)H oxidase in coronary arterial myocytes Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H483 - H495. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lakshminrusimha, J. A. Russell, S. F. Gugino, R. M. Ryan, B. Mathew, L. C. Nielsen, and F. C. Morin III Adjacent bronchus attenuates pulmonary arterial contractility Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L473 - L478. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Gao, K. Takemori, L.-Y. Su, W.-S. An, C. Lu, A. M. Sharma, and R. M.K.W. Lee Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion Cardiovasc Res, July 15, 2006; 71(2): 363 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weaver, J. Liu, D. Pimentel, D. J. Reddy, P. Harding, E. L. Peterson, and P. J. Pagano Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1933 - H1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. An, R. Boyd, Y. Wang, X. Qiu, and H. D. Wang Endothelin-1 expression in vascular adventitial fibroblasts Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H700 - H708. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F.H. Mueller, K. Laude, J. S. McNally, and D. G. Harrison Redox Mechanisms in Blood Vessels Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 274 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Somoza, M. C. Gonzalez, J. M. Gonzalez, F. Abderrahim, S. M. Arribas, and M. S. Fernandez-Alfonso Modulatory role of the adventitia on noradrenaline and angiotensin II responses: Role of endothelium and AT2 receptors Cardiovasc Res, February 1, 2005; 65(2): 478 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Quinn and K. A. Gauss Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases J. Leukoc. Biol., October 1, 2004; 76(4): 760 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lopez-Lopez, L. Moreno, A. Cogolludo, M. Galisteo, M. Ibarra, J. Duarte, F. Lodi, J. Tamargo, and F. Perez-Vizcaino Nitric Oxide (NO) Scavenging and NO Protecting Effects of Quercetin and Their Biological Significance in Vascular Smooth Muscle Mol. Pharmacol., April 1, 2004; 65(4): 851 - 859. [Abstract] [Full Text] |
||||
![]() |
J. Kawai, K. Ando, A. Tojo, T. Shimosawa, K. Takahashi, M. L. Onozato, M. Yamasaki, T. Ogita, T. Nakaoka, and T. Fujita Endogenous Adrenomedullin Protects Against Vascular Response to Injury in Mice Circulation, March 9, 2004; 109(9): 1147 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K Shieh, E. Kotlyar, and F. Sam Aldosterone and cardiovascular remodelling: focus on myocardial failure Journal of Renin-Angiotensin-Aldosterone System, March 1, 2004; 5(1): 3 - 13. [Abstract] [PDF] |
||||
![]() |
A. H. Chamseddine and F. J. Miller Jr. gp91phox Contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2284 - H2289. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mazurek, L. Zhang, A. Zalewski, J. D. Mannion, J. T. Diehl, H. Arafat, L. Sarov-Blat, S. O'Brien, E. A. Keiper, A. G. Johnson, et al. Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators Circulation, November 18, 2003; 108(20): 2460 - 2466. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-S. Zhou, A. G. Adam, E. A. Jaimes, and L. Raij In Salt-Sensitive Hypertension, Increased Superoxide Production Is Linked to Functional Upregulation of Angiotensin II Hypertension, November 1, 2003; 42(5): 945 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lassegue and R. E. Clempus Vascular NAD(P)H oxidases: specific features, expression, and regulation Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R277 - R297. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, A. Zalewski, Y. Liu, T. Mazurek, S. Cowan, J. L. Martin, S. M. Hofmann, H. Vlassara, and Y. Shi Diabetes-Induced Oxidative Stress and Low-Grade Inflammation in Porcine Coronary Arteries Circulation, July 29, 2003; 108(4): 472 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C.M Siow, C. M Mallawaarachchi, and P. L Weissberg Migration of adventitial myofibroblasts following vascular balloon injury: insights from in vivo gene transfer to rat carotid arteries Cardiovasc Res, July 1, 2003; 59(1): 212 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sudhandiran and C. Shaha Antimonial-induced Increase in Intracellular Ca2+ through Non-selective Cation Channels in the Host and the Parasite Is Responsible for Apoptosis of Intracellular Leishmania donovani Amastigotes J. Biol. Chem., June 27, 2003; 278(27): 25120 - 25132. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Duquaine, G. A Hirsch, A. Chakrabarti, Z. Han, C. Kehrer, R. Brook, J. Joseph, A. Schott, B Kalyanaraman, J. Vasquez-Vivar, et al. Rapid-onset endothelial dysfunction with adriamycin: evidence for a dysfunctional nitric oxide synthase Vascular Medicine, May 1, 2003; 8(2): 101 - 107. [Abstract] [PDF] |
||||
![]() |
G. M. Jacobson, H. M. Dourron, J. Liu, O. A. Carretero, D. J. Reddy, T. Andrzejewski, and P. J. Pagano Novel NAD(P)H Oxidase Inhibitor Suppresses Angioplasty-Induced Superoxide and Neointimal Hyperplasia of Rat Carotid Artery Circ. Res., April 4, 2003; 92(6): 637 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Watanabe, Y. Chu, J. J. Andresen, H. Nakane, F. M. Faraci, and D. D. Heistad Gene Transfer of Extracellular Superoxide Dismutase Reduces Cerebral Vasospasm After Subarachnoid Hemorrhage Stroke, February 1, 2003; 34(2): 434 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Rey and P. J. Pagano The Reactive Adventitia: Fibroblast Oxidase in Vascular Function Arterioscler Thromb Vasc Biol, December 1, 2002; 22(12): 1962 - 1971. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Rey, X.-C. Li, O. A. Carretero, J. L. Garvin, and P. J. Pagano Perivascular Superoxide Anion Contributes to Impairment of Endothelium-Dependent Relaxation: Role of gp91phox Circulation, November 5, 2002; 106(19): 2497 - 2502. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sun, J. Zhang, L. Lu, S. S. Chen, M. T. Quinn, and K. T. Weber Aldosterone-Induced Inflammation in the Rat Heart : Role of Oxidative Stress Am. J. Pathol., November 1, 2002; 161(5): 1773 - 1781. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Kim, Y. S. Suh, M.-S. Lee, K. Y. Kim, J. H. Lee, H. S. Lee, K. W. Hong, and C. D. Kim Vascular NAD(P)H Oxidase Triggers Delayed Cerebral Vasospasm After Subarachnoid Hemorrhage in Rats Stroke, November 1, 2002; 33(11): 2687 - 2691. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Munzel, I. B. Afanas'ev, A. L. Kleschyov, and D. G. Harrison Detection of Superoxide in Vascular Tissue Arterioscler Thromb Vasc Biol, November 1, 2002; 22(11): 1761 - 1768. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zalewski, Y. Shi, and A. G. Johnson Diverse Origin of Intimal Cells: Smooth Muscle Cells, Myofibroblasts, Fibroblasts, and Beyond? Circ. Res., October 18, 2002; 91(8): 652 - 655. [Full Text] [PDF] |
||||
![]() |
F. Perez-Vizcaino, J. G. Lopez-Lopez, R. Santiago, A. Cogolludo, F. Zaragoza-Arnaez, L. Moreno, M. J. Alonso, M. Salaices, and J. Tamargo Postnatal maturation in nitric oxide-induced pulmonary artery relaxation involving cyclooxygenase-1 activity Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L839 - L848. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Van Heerebeek, C Meischl, W Stooker, C J L M Meijer, H W M Niessen, and D Roos NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system? J. Clin. Pathol., August 1, 2002; 55(8): 561 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Guzik, N. E.J. West, R. Pillai, D. P. Taggart, and K. M. Channon Nitric Oxide Modulates Superoxide Release and Peroxynitrite Formation in Human Blood Vessels Hypertension, June 1, 2002; 39(6): 1088 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. JAVESGHANI, S. A. MAGDER, E. BARREIRO, M. T. QUINN, and S. N. A. HUSSAIN Molecular Characterization of a Superoxide-Generating NAD(P)H Oxidase in the Ventilatory Muscles Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 412 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Katoh, Y. Kurosawa, K. Tanaka, A. Watanabe, H. Doi, and H. Narita Fluvastatin inhibits O2- and ICAM-1 levels in a rat model with aortic remodeling induced by pressure overload Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H655 - H660. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shi, S. Patel, K. L. Davenpeck, R. Niculescu, E. Rodriguez, M. G. Magno, M. L. Ormont, J. D. Mannion, and A. Zalewski Oxidative Stress and Lipid Retention in Vascular Grafts : Comparison Between Venous and Arterial Conduits Circulation, May 15, 2001; 103(19): 2408 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Miller Jr Adventitial Fibroblasts : Backstage Journeymen Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 722 - 723. [Full Text] [PDF] |
||||
![]() |
Y. Shi, R. Niculescu, D. Wang, S. Patel, K. L. Davenpeck, and A. Zalewski Increased NAD(P)H Oxidase and Reactive Oxygen Species in Coronary Arteries After Balloon Injury Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 739 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Hink, H. Li, H. Mollnau, M. Oelze, E. Matheis, M. Hartmann, M. Skatchkov, F. Thaiss, R. A. K. Stahl, A. Warnholtz, et al. Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus Circ. Res., February 2, 2001; 88 (2): e14 - e22. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gielen, G. Schuler, and R. Hambrecht Exercise Training in Coronary Artery Disease and Coronary Vasomotion Circulation, January 2, 2001; 103 (1): e1 - e6. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Steinhorn, J. A. Russell, S. Lakshminrusimha, S. F. Gugino, S. M. Black, and J. R. Fineman Altered endothelium-dependent relaxations in lambs with high pulmonary blood flow and pulmonary hypertension Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H311 - H317. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Thannickal and B. L. Fanburg Reactive oxygen species in cell signaling Am J Physiol Lung Cell Mol Physiol, December 1, 2000; 279(6): L1005 - L1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Cifuentes, F. E. Rey, O. A. Carretero, and P. J. Pagano Upregulation of p67phox and gp91phox in aortas from angiotensin II-infused mice Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2234 - H2240. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.Y. Alexander, M.J. Brosnan, C. A. Hamilton, J. P. Fennell, E. C. Beattie, E. Jardine, D. D. Heistad, and A. F. Dominiczak Gene transfer of endothelial nitric oxide synthase but not Cu/Zn superoxide dismutase restores nitric oxide availability in the SHRSP Cardiovasc Res, August 18, 2000; 47(3): 609 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Pagano Vascular gp91phox : Beyond the Endothelium Circ. Res., July 7, 2000; 87(1): 1 - 3. [Full Text] [PDF] |
||||
![]() |
C. Berry, C. A. Hamilton, M. J. Brosnan, F. G. Magill, G. A. Berg, J. J. V. McMurray, and A. F. Dominiczak Investigation Into the Sources of Superoxide in Human Blood Vessels : Angiotensin II Increases Superoxide Production in Human Internal Mammary Arteries Circulation, May 9, 2000; 101(18): 2206 - 2212. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Somers, K. Mavromatis, Z. S. Galis, and D. G. Harrison Vascular Superoxide Production and Vasomotor Function in Hypertension Induced by Deoxycorticosterone Acetate-Salt Circulation, April 11, 2000; 101(14): 1722 - 1728. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, S.-J. Chen, S. Oparil, Y.-F. Chen, and J. A. Thompson Direct In Vivo Evidence Demonstrating Neointimal Migration of Adventitial Fibroblasts After Balloon Injury of Rat Carotid Arteries Circulation, March 28, 2000; 101(12): 1362 - 1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gu and P. Brecher Nitric Oxide-Induced Increase in p21Sdi1/Cip1/Waf1 Expression During the Cell Cycle in Aortic Adventitial Fibroblasts Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 27 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Wagner, T. Kohler, U. Ruckschloss, I. Just, and M. Hecker Improvement of Nitric Oxide-Dependent Vasodilatation by HMG-CoA Reductase Inhibitors Through Attenuation of Endothelial Superoxide Anion Formation Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 61 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jeserich, T. Schindler, M. Olschewski, M. Unmussig, H. Just, and U. Solzbach Vitamin C improves endothelial function of epicardial coronary arteries in patients with hypercholesterolaemia or essential hypertension--assessed by cold pressor testing Eur. Heart J., November 2, 1999; 20(22): 1676 - 1680. [Abstract] [PDF] |
||||
![]() |
P. J. Pagano, M. C. Griswold, S. Najibi, S. L. Marklund, and R. A. Cohen Resistance of endothelium-dependent relaxation to elevation of O-2 levels in rabbit carotid artery Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H2109 - H2114. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Gutterman Adventitia-dependent influences on vascular function Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1265 - H1272. [Full Text] [PDF] |
||||
![]() |
G. Kojda and D. Harrison Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure Cardiovasc Res, August 15, 1999; 43(3): 652 - 671. [Full Text] [PDF] |
||||
![]() |
A. M Dart and J. P.F Chin-Dusting Lipids and the endothelium Cardiovasc Res, August 1, 1999; 43(2): 308 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Wang, S. Hope, Y. Du, M. T. Quinn, A. Cayatte, P. J. Pagano, and R. A. Cohen Paracrine Role of Adventitial Superoxide Anion in Mediating Spontaneous Tone of the Isolated Rat Aorta in Angiotensin II-Induced Hypertension Hypertension, May 1, 1999; 33(5): 1225 - 1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Cohen The potential clinical impact of 20 years of nitric oxide research Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1404 - H1407. [Full Text] [PDF] |
||||
![]() |
S. S. Brar, T. P. Kennedy, A. B. Sturrock, T. P. Huecksteadt, M. T. Quinn, T. M. Murphy, P. Chitano, and J. R. Hoidal NADPH oxidase promotes NF-kappa B activation and proliferation in human airway smooth muscle Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L782 - L795. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Wang, D. G. Johns, S. Xu, and R. A. Cohen Role of superoxide anion in regulating pressor and vascular hypertrophic response to angiotensin II Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1697 - H1702. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Wang, S. Xu, D. G. Johns, Y. Du, M. T. Quinn, A. J. Cayatte, and R. A. Cohen Role of NADPH Oxidase in the Vascular Hypertrophic and Oxidative Stress Response to Angiotensin II in Mice Circ. Res., May 9, 2001; 88(9): 947 - 953. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, K. Terata, N. J. Rusch, and D. D. Gutterman High Glucose Impairs Voltage-Gated K+ Channel Current in Rat Small Coronary Arteries Circ. Res., July 20, 2001; 89(2): 146 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Rey, M. E. Cifuentes, A. Kiarash, M. T. Quinn, and P. J. Pagano Novel Competitive Inhibitor of NAD(P)H Oxidase Assembly Attenuates Vascular O2- and Systolic Blood Pressure in Mice Circ. Res., August 31, 2001; 89(5): 408 - 414. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |